Sheilagh Maguiness, MD

Assistant Professor, Department of Dermatology

Sheilagh Maguiness

Contact Info

Fax 612-365-8201

Mailing Address:
Department of Dermatology
420 Delaware St.SE
MMC 98
Minneapolis, MN 55455

Administrative Assistant Name
Heidi Menzel (Non-clinical)

Administrative Phone
612-625-8625

Administrative Email
dermadmin@umn.edu

Assistant Professor, Department of Dermatology


MD, University of Western Ontario, London, ON, Canada

Residency, University of Alberta, Edmonton, AB, Canada

Fellowship, University of California-San Francisco (Pediatric Dermatology)

Summary

If you would like to schedule an appointment with Dr. Maguiness, please call:

(612) 365-6777 - Pediatric Dermatology Clinic
(763) 898-1440 - M Health Maple Grove Clinic

Awards & Recognition

2019 Resident Teacher of the Year, Department of Dermatology University of Minnesota

2018 Distinguished Mentorship Award, University of Minnesota Medical School

2018 Minnesota Monthly Magazine:Top Doctors, 2016, 2017, 2018, 2019

2018 Academic Dermatology Advanced Leadership Program, competitively selected to participate

2017 Presidential Citation, American Academy of Dermatology for contribution to the Basic Dermatology Curriculum

2017 University of Minnesota Department of Dermatology Research Day Outstanding Abstract

2015 University of Minnesota Masonic Children’s Hospital Cross Departmental Research Grant

2015 Walt Tunnessen Visiting Professor Speaker List, American Academy of Pediatrics

2015 National Eczema Association ‘Hero’

2011 Selected Member, Academic Dermatology Leadership Program, AAD

2003 First Place, Resident Research Award, Canadian Dermatology Association

2001 Norma Fletcher Award, University of Western Ontario

2000 Ivan Smith Award, University of Toronto

Professional Associations

Minnesota Dermatological Society  2014-Present

American Academy of Pediatrics Section on Dermatology  2014- present

American Academy of Pediatrics  2013-Present

Section on Dermatology, Executive Committee  2017-Present

Chair, AAP Section on Dermatology Education Sub-committee  2018-Present

Pediatric Dermatology Research Alliance  2013-Present

New England Dermatologic Society  2011-2014

International Society for the Study of Vascular Anomalies  2010-Present

ISSVA Poster Judging Committee  2018

American Board of Dermatology  2007-Present

Royal College of Physicians and Surgeons of Canada  2007-Present

Society for Pediatric Dermatology  2006-Present

Vice President Education and Career Development  2017-Present

Chair, Education Committee  2014-2017

Annual Meeting Course Director  2014

Poster Judging Committee  2013

<

Research

Publications

Recent Key Publications


1.Frieden IJ, Püttgen KB, Drolet BA, Garzon MC, Chamlin SL, Pope E, Mancini AJ, Lauren CT, Mathes EF, Siegel DH, Gupta D, Maguiness, S. Management of Infantile Hemangiomas during the COVID Pandemic. Pediatric Dermatology. 2020 Apr 16.

2.Reynolds SD, Mathur AN, Chiu YE, Brandling-Bennett H, Pope E, Siegel M, Holland K, Paller A, Siegfried E, Tom W, Lara-Corrales I, Tollefson M, Maguiness S, Eichenfield L, Sugarman J, Frieden I, Oza V, Cipriano S, Huang J, Shah S, Lauren C, Castelo-Soccio L, McMahon P, Cordoro K. Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic [published online ahead of print, 2020 Apr 22]. Pediatr Dermatol. 2020;10.1111/pde.14202. doi:10.1111/pde.14202

3.Luu M, Halbert A, Yan A, Rubin A, McMahon P, Liang M, Vadeboncoeur S, Frieden IJ, Maguiness S. Cutaneous manifestations of congenital malignant rhabdoid tumor: Unusual papillomatous plaques and other skin presentations. Pediatric Dermatology. 2020 Apr 23.

4.Correll CK, Miller DD, Maguiness SM. Treatment of Childhood-Onset Lupus Erythematosus Panniculitis With Rituximab. JAMA dermatology. 2020 May 1;156(5):566-9.

5.Dodds M, Tollefson M, Castelo‐Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series. Pediatric Dermatology. 2020 Mar;37(2):272-7.

6.Nguyen CV, Collier S, Merten AH, Maguiness SM, Hook KP. Tinea capitis: A single‐institution retrospective review from 2010 to 2015. Pediatric dermatology. 2020 Mar;37(2):305-10.

7.Dodds M, Maguiness S. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans. Pediatric dermatology. 2019 Jul;36(4):554-5.

8.Schultz B, Miller DD, Maguiness S. Diffuse, mottled hyperpigmentation and mutations in LMNA gene in a 5‐year‐old boy, his mother, and his grandmother: Atypical progeroid syndrome. Pediatric dermatology. 2019 Nov;36(6):913-7.

9.Liszewski W, Maguiness S, Greengard E, Boull C. The incidence of pediatric malignant soft tissue tumors of the skin and subcutaneous tissue. Pediatr Dermatol. 2018;35(6):e427‐e429. doi:10.1111/pde.13669

10.Mansh M, Riskalla M, Maguiness S.Necrotizing Anogenital Ulcer in a Healthy 8-Month-Old Male.JAMA Dermatol. Published online May 16, 2018.  Doi:10.001/jamadermatol.2018.0287.

Clinical

Board Certifications

Board Certifications

Dermatology, Pediatric Dermatology Fellow of the Royal College of Physicians and Surgeons of Canada

Care Philosophy

I am a pediatric dermatologist with special interest in the diagnosis and management of vascular anomalies including hemangiomas, capillary malformations (port wine stains) and complex vascular birthmarks. I am committed to patient care, teaching and research in all aspects of pediatric der

Clinical Interests

Vascular Anomalies: Hemangiomas, Port Wine Stain/Capillary malformations, Venous malformations Laser treatment of Vascular Birthmarks Pigmented lesions and other Birthmarks Inflammatory skin diseases: Atopic Dermatitis, Psoriasis